(P-1933) Co-Administration of Triazoles with Chemotherapy and/or Immunosuppressants Known to Have Moderate-to-Severe Drug-Drug Interactions in Patients with Hematologic Malignancies Who Are Hospitalized for Invasive Aspergillosis

Founding Director
Center for Innovative Therapeutics and Diagnostics (citdx.org)
Richmond, VA, United States

Professor
University of Connecticut School of Pharmacy
Storrs, CT, United States

Professor of Medicine
Duke University
Durham, North Carolina, United States

Senior Director, Heath Economics and Outcomes Research
F2G, Inc.
Princeton, New Jersey, United States

Professor of Medicine, Professor of Pathology
Duke University School of Medicine
Durham, North Carolina, United States